Back to Westfield Capital Management Co. LP Westfield Capital Management Co. LP

NVCR

3 quarters

Position history for Westfield Capital Management Co. LPWestfield Capital Management Co. LP's holdings in NovoCure Limited

No. Westfield Capital Management exited its NVCR (NovoCure) position in Q2 2019. Its Q1 2019 13F listed 305,185 shares worth $14.7M. Westfield Capital Management already held NVCR in its Q4 2018 13F, the earliest on record, and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$23M

Total Shares Change

-685,890

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2019-Q2
Latest
Exited
0
-100.0%
$00.0%$63.23
0
2019-Q1
Decreased
305,185
-55.5%
$14.7M0.1%$48.17
0
2018-Q4
First report
685,890
-
$23M0.2%$33.48
0

Other major holders of NVCR: Capital World Investors, FMR LLC, Baillie Gifford & Co., Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used